NGB Diagnostics

Delhi, India
Offers next-generation sequencing and proteomic solutions for diagnostics and research.
Request Access
Report Incorrect Data
Annual revenue $407,679 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 5 Services tracked
Competitors 7 Brand Intelligence

About NGB Diagnostics

NGB Diagnostics is a company based in Delhi (India) by Rakesh Maurya. It operates as a B2B. NGB Diagnostics offers products and services including Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification. NGB Diagnostics operates in a competitive market with competitors including Abcam, Arbor Biotechnologies, Singleron, Stem Cell Technologies and Octant, among others.

  • Headquarter Delhi, India
  • Founders Rakesh Maurya
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Ngb Diagnostics Private Limited
  • Date of Incorporation 05 Jun, 2012
  • Jurisdiction New Delhi, Delhi, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research → →
Key Metrics
  • Annual Revenue
    $407.68 K (USD)
    -31.69
    as on Mar 31, 2023
  • Net Profit
    $6.06 K (USD)
    -36.19
    as on Mar 31, 2023
  • EBITDA
    $9.02 K (USD)
    -35.19
    as on Mar 31, 2023
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of NGB Diagnostics

NGB Diagnostics offers a comprehensive portfolio of products and services, including Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification.

Primary

Service for sequencing entire genomes for research.

Sequencing of exomes for targeted genetic analysis.

Analysis of RNA transcripts for gene expression studies.

Identification of proteins using advanced techniques.

Quantification method for proteomic profiling.

Funding Insights of NGB Diagnostics

Investments & Acquisitions by NGB Diagnostics

Investments

Financial Statements - NGB Diagnostics

Ngb Diagnostics Comparisons

+
Add Comparison
Available on Premium

Competitors of NGB Diagnostics

NGB Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Arbor Biotechnologies, Singleron, Stem Cell Technologies and Octant, among others.

Company Name Domain Founded year HQ Location Description
Abcam
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
Arbor Biotechnologies
domain founded_year HQ Location
Genomic technologies and drug discovery platforms are provided.
Singleron
domain founded_year HQ Location
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis
Stem Cell Technologies
domain founded_year HQ Location
Developer of cell culture media and ancillary reagents for life science research
Octant
domain founded_year HQ Location
Human cell interaction platform is provided for drug discovery.
Meridian Bioscience
domain founded_year HQ Location
Molecular diagnostic device and kits

Latest news on Ngb Diagnostics

Frequently Asked Questions about NGB Diagnostics

NGB Diagnostics is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Rakesh Maurya is the current CEO of NGB Diagnostics. They have also founded this company.

Annual revenue of NGB Diagnostics is $407.68K as on Mar 31, 2023.

NGB Diagnostics Private Limited, founded in 2012, delivers high-quality genomics and proteomics services using advanced bioinformatic pipelines. They specialize in whole genome sequencing, RNA sequencing, and protein analysis for clinical diagnostics, pharmaceutical, RD, and agro-food sectors. Based in India, they focus on affordable solutions with certified laboratories and cater to clients in healthcare and biotechnology industries.

NGB Diagnostics's top competitors include Abcam, Arbor Biotechnologies and Meridian Bioscience.

NGB Diagnostics offers Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Protein Identification, and iTRAQ Protein Quantification.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available